
The Associated Press @AP
The FDA issued a negative review of an experimental drug for the illness known as Lou Gehrig’s disease. The drug has become a rallying cause for patients with ALS and members of Congress who’ve joined in pushing the FDA for approval. https://t.co/C8c3CIWimj — PolitiTweet.org